243 related articles for article (PubMed ID: 23375977)
1. Chlamydia trachomatis control requires a vaccine.
Brunham RC; Rappuoli R
Vaccine; 2013 Apr; 31(15):1892-7. PubMed ID: 23375977
[TBL] [Abstract][Full Text] [Related]
2. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
[TBL] [Abstract][Full Text] [Related]
3. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
4. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
5. National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward".
Zhong G; Brunham RC; de la Maza LM; Darville T; Deal C
Vaccine; 2019 Nov; 37(50):7346-7354. PubMed ID: 29097007
[TBL] [Abstract][Full Text] [Related]
6. Update on Chlamydia trachomatis Vaccinology.
de la Maza LM; Zhong G; Brunham RC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
[TBL] [Abstract][Full Text] [Related]
7. Considerations for the rational design of a Chlamydia vaccine.
Liang S; Bulir D; Kaushic C; Mahony J
Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.
Chavez JM; Vicetti Miguel RD; Cherpes TL
Infect Dis Obstet Gynecol; 2011; 2011():754060. PubMed ID: 22144851
[TBL] [Abstract][Full Text] [Related]
9. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
10. [Development of vaccine preparation for urogenital Chlamydiosis prophylaxis].
Koroleva EA; Zigangirova NA
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):114-23. PubMed ID: 22308743
[TBL] [Abstract][Full Text] [Related]
11. Action Needed on Chlamydia Vaccines.
Starnbach MN
Trends Microbiol; 2018 Aug; 26(8):639-640. PubMed ID: 29858127
[TBL] [Abstract][Full Text] [Related]
12. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
Poston TB; Gottlieb SL; Darville T
Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
[TBL] [Abstract][Full Text] [Related]
13. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
[TBL] [Abstract][Full Text] [Related]
15. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.
Frietze KM; Lijek R; Chackerian B
Expert Rev Vaccines; 2018 Nov; 17(11):959-966. PubMed ID: 30300019
[TBL] [Abstract][Full Text] [Related]
16. Towards a Chlamydia vaccine. Interview by Kelly McCauley.
Igietseme J
Expert Rev Vaccines; 2004 Jun; 3(3):237-42. PubMed ID: 15176940
[No Abstract] [Full Text] [Related]
17. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
18. Perspective: my 37 year journey through Chlamydia research: Chlamydia antigen analysis using monoclonal antibodies and major histocompatibility complex molecules.
Brunham RC
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28961985
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for Chlamydia infections of the female genital tract.
Hafner LM; McNeilly C
Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
